Business Description
SpyGlass Pharma is a California-based drug company focused on treating chronic eye diseases, particularly glaucoma. Its main product is a small drug-releasing device that attaches to an artificial lens and is inserted into the eye during routine cataract surgery, helping to lower harmful pressure buildup. The company is also working on a separate ring-shaped implant that delivers the same medication over time without requiring a lens replacement.
